Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar 16;87(2-3):303-11.
doi: 10.1016/j.drugalcdep.2006.09.003. Epub 2006 Oct 30.

Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use

Krista Lisdahl Medina  1 , Paula K Shear
Affiliations

Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use

Krista Lisdahl Medina et al. Drug Alcohol Depend. .

Abstract

Background: Given ecstasy's (MDMA) potential serotonergic neurotoxicity, it is plausible that regular ecstasy users would have an elevated prevalence of behavioral executive dysfunction or mood symptoms. However, recent studies have found that the relationship between ecstasy use and psychological symptoms was no longer significant after controlling for marijuana use (e.g., Morgan et al., 2002). The goal of the present study was to examine the relationship between ecstasy exposure and self-reported executive functioning and psychological symptoms after controlling for gender, ethnicity, and other drug use.

Methods: Data were collected from 65 men and women with a wide range of ecstasy use (including 17 marijuana-using controls). Participants were administered the Frontal Systems Behavioral Scale, State-Trait Anxiety Inventory for adults, and the Beck Depression Inventory-2nd edition.

Results: Although 19-63% of the ecstasy users demonstrated clinically elevated psychological symptoms, frequency of ecstasy use did not predict the psychological symptoms. No gender differences or interactions were observed.

Conclusions: These results revealed that, although ecstasy users demonstrate elevated levels of psychological symptoms and executive dysfunction, these symptoms are not statistically associated with their ecstasy consumption. Instead, other drug use (alcohol, marijuana, opioids, and inhalants) significantly predict psychological symptoms in this sample of polydrug users.

PubMed Disclaimer

References

    1. Ahmadi J, Farrashbandi H, Menzies P, Majdi B, Ahmadi F, Babaee MA, Esmaeelian G, Ahmadi M, Rahnama A, Ahmadi F, et al. Prevalence of mood and anxiety disorders in a sample of Iranian outpatient opioid addicts. German J of Psychiatry. 2005;8(1):5–7.
    1. Beck AT. Beck Depression Inventory. 2. New York: Psychological Corporation; 1996.
    1. Bolla KI, McCann UD, Ricaurte GA. Memory impairment in abstinent MDMA (“Ecstasy”) users. Neurology. 1998;51:1532–1537. - PubMed
    1. Boyd CJ, McCabe SE, d’Arcy H. Ecstasy use among college undergraduates: gender, race, and sexual identity. J Subst Abuse Treat. 2003;24:209–215. - PubMed
    1. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid metabolites. Psychiatry Res. 1979;1:131–139. - PubMed

Publication types

Substances